00910nas a2200337   4500000000100000008004100001260001300042653001500055653001000070653000900080653001000089653002900099653001200128653003000140653001100170653001100181653001200192653000900204653001600213653002500229653001700254653001300271653000900284100001700293700001700310700001800327245019600345300001000541490000700551022001400558       1979                            d  c1979 Mar10aAdolescent10aAdult10aAged10aChild10aClinical Trials as Topic10aDapsone10aDrug Therapy, Combination10aFemale10aHumans10aleprosy10aMale10aMiddle Aged10aMycobacterium leprae10aNasal Mucosa10aRifampin10aSkin1 aLanguillon J1 aYawalkar S J1 aMcDougall A C00aTherapeutic effects of adding rimactane (rifampicin) 450 milligrams daily or 1200 milligrams once monthly in a single dose to dapsone 50 milligrams daily in patients with lepromatous leprosy.  a37-430 v47  a0148-916X